Skip to main content
. Author manuscript; available in PMC: 2023 Nov 15.
Published in final edited form as: Circ Cardiovasc Imaging. 2022 Nov 15;15(11):e014229. doi: 10.1161/CIRCIMAGING.122.014229

Table 1.

Changes in serum lipids and apolipoproteins.

Variable Baseline Follow-up P-value*

Total cholesterol, mg/dl 145 ± 31 144 ± 28 0.73
LDL cholesterol, mg/dl 76 ± 27 72 ± 23 0.082
Triglycerides, mg/dl 162 (127 – 206) 144 (112 – 200) 0.011
HDL cholesterol, mg/dl 35 ± 6 40 ± 9 <0.001
ApoB, mg/dl 86 ± 23 77 ± 19 <0.001
ApoA-I, mg/dl 122 ± 17 131 ± 20 <0.001
ApoB:ApoA-I ratio 0.72 ± 0.20 0.60 ± 0.17 <0.001
Lp(a)§, nmol/L 32 (14 – 149) 28 (10 – 109) <0.001

LDL: Low-density lipoprotein, HDL; high-density lipoprotein. Values are mean ± standard deviation or median (inter-quartile range) unless otherwise specified;

*

Wilcoxon signed-rank test comparing baseline and follow-up measurements.

One subject missing the follow-up value was excluded;

Three subjects missing baseline or follow-up values were excluded;

§

Follow-up measurements were performed at 1 year.